Abstract
Purpose
To evaluate the diagnostic and prognostic utility of the atrophy-traction-neovascularization (ATN) classification in characterizing myopic maculopathy (MM) and identifying factors influencing its subtypes and visual outcomes.
Methods
228 eyes (136 patients) with high myopia [spherical equivalent (SE) ≤ −6.00 diopters (D) or axial length (AL) ≥ 26.5 mm] were assessed. Ocular evaluations included optical coherence tomography and ocular biometry. MM was classified into three subtypes: myopic atrophy-maculopathy (MAM), myopic tractional-maculopathy (MTM), and myopic neovascular-maculopathy (MNM). Final corrected-distance-visual-acuity (CDVA), AL, and SE were compared between eyes with and without MM and its subtypes. Univariate and multivariate models were used to identify related factors in each subtype: moderate-severe vision impairment (final CDVA between 20/70–20/400) and blindness (final CDVA < 20/400).
Results
MM was present in 58.8% of cases, 52.2% had MAM, 27.2% MNM and 14% MNM. Notably, fifteen eyes (11.2%) exhibited traction or neovascularization without atrophy. Eyes with MM exhibited worse BCVA, more negative SE, and longer AL than those without MM (p < 0.001). AL ≥ 30 mm was related to MAM (OR = 1.51; 95% CI 1.30–3.00; p = 0.004) and MNM (OR = 9.36; 95% CI 1.56–13.08; p = 0.021). Blindness was related to aged ≥ 50 years (OR = 2.80; 95% CI 1.30–6.05; p = 0.010), MTM (OR = 1.90; 95% CI 1.80–4.80; p = 0.029), and MNM (OR = 5.60; 95% CI 2.78–15.55; p = 0.005).
Conclusion
The ATN classification is valuable for diagnosing and prognosing MM, as it identifies subtypes and key factors influencing visual outcomes. Notably, tractional and neovascular changes, detected in ATN but often undetectable on fundus photography, were linked to worse visual prognosis, reinforcing its clinical relevance.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
